医药分家

如今，我国实施的医药分家、药品招标制、医疗保险、药企GMP准入制度等，都给医药行业带来巨大的机遇。

Nowadays , the implementation of the medical centre . drugs competitive bidding system , yearly medical insurance , medicine enterprises GMP admittance system etc. , all give medicine industry has brought tremendous opportunities .

同时国家出台药品降价、医药分家、大力开拓农村市场、加快GSP认证工作等一系列医药行业政策。

At the same time , government enacts some important policy , such as decrease of drug price , division of medical treatment and drug sale , exploitation in country market and GSP certification etc.

然而新医改的医药分家要求，以及信息化时代的加速，这种信息不对称要被打破。

However , because of new medical reform the separation requirements , and accelerated the information age , this information asymmetry will be broken .

另外，近年来国家的医药分家政策也客观上迫使医院大量采购医疗器械来提高医院的竞争力。

Moreover , the policy of separation of hospital and medicine has objectively forced the hospitals to purchase lots of medical equipment to raise their competitive strength .

因此，让医药分家，使医疗机构、医务人员与药品利益脱钩，使医生的报酬里面体现其真正的劳动价值，成为医疗改革的主要目的。

To make medical institutions , medical personnel and drug benefit decoupling and to make the payment of the doctor reflecting its real labor value are the main purpose of the health care reform .

目的：通过比较相关数据，评价医药分家改革对社区卫生服务机构、患者和医药销售公司的影响。

Objective Investigate and evaluate the effect of the reform for the separation of prescribing and dispensing on the community health service , patients , and pharmaceutical sales companies through analyzing and comparing the collected data .